Loading insider details...
Beta
Latest Form 4 (May 8, 2026): Exercise/Conversion of 34,819 AMRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 8, 2026 | Amneal Pharmaceuticals, Inc. (AMRX) | Exercise/Conversion | 34,819 | n/a |
| May 8, 2026 | Philip Morris International Inc. (PM) | Grant/Award | 1,119 | $190.2K |
| May 9, 2025 | Philip Morris International Inc. (PM) | Grant/Award | 1,002 | $175.2K |
| May 8, 2025 | Amneal Pharmaceuticals, Inc. (AMRX) | Exercise/Conversion | 40,258 | n/a |
| May 14, 2024 | Amneal Pharmaceuticals, Inc. (AMRX) | Exercise/Conversion | 76,453 | n/a |
| May 10, 2024 | Philip Morris International Inc. (PM) | Grant/Award | 1,789 | $175.0K |
| May 6, 2024 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/Award | 40,258 | n/a |
| May 11, 2023 | Amneal Pharmaceuticals, Inc. (AMRX) | Exercise/Conversion | 80,128 | n/a |
| May 5, 2023 | Philip Morris International Inc. (PM) | Grant/Award | 1,812 | $175.0K |
| May 10, 2022 | Amneal Pharmaceuticals, Inc. (AMRX) | Exercise/Conversion | 35,406 | n/a |